EligibleTrials

Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

Recruiting · NCT06247397 · Interventional (participants receive a specific treatment) · Lead sponsor: Skane University Hospital

View the official record on ClinicalTrials.gov →
COPD

Interventions studied

Added high-flow oxygen therapyStandard care

What this trial is about

This is a registry-based, randomized, controlled clinical trial of the effect of added high-flow oxygen therapy (using the device Lumis HFT) during one year in people with long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.